Paragon is capable of taking a client from construction of an expression vector, to performing process development (both upstream and downstream) and into GMP manufacturing of biologics specifically for Phase I/II clinical trials. Thoughtful selection of the company's staff, equipment, utilities, and facilities expressly for small batch manufacturing is intended to minimize overhead and thereby maximize a client's return on investment.